Home Newsfeeds Raymond James Maintains Outperform on Gossamer Bio, Raises Price Target to $14

Raymond James Maintains Outperform on Gossamer Bio, Raises Price Target to $14

Raymond James analyst Steven Seedhouse maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $10 to $14.

byBenzinga Newsdesk

July 14, 2022

1 minute read

Raymond James analyst Steven Seedhouse maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $10 to $14.

Sidus Space Awarded Additional Space Hardware Manufacturing In Support Of NASA’s Artemis Program And Space Launch System Manned Vehicle; Shares Move Higher

By Happy Mohamed

June 2, 8:34 AM

Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), a multi-faceted Space and Defense-as-a-Service satellite company announces the award of an additional hardware manufacturing subcontract to

LDOS

Ohmyhome Signs MOU For Potential Acquisition Of A Leading Singapore Tech-Enabled Property Management Company To Deliver Quality Services Directly To Customers’ Fingertips And Doorsteps

By Happy Mohamed

May 16, 9:39 AM

Upon successful closing of the transaction, thousands of residents in Singapore will immediately be able to access Ohmyhome's quality services. Post-integration of the technologies and operations of

OMH

Why Summit Materials Stock Is Trading Lower Today

By Nabaparna Bhattacharya

September 7, 11:45 AM

Summit Materials, Inc. (NYSE: SUM) shares are trading lower after the company announced a combination with Argos North America Corp. (Argos USA), the U.S.

SUM